Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 106 results found. Search for [ Coronavirus drug Gilead ]

Results 1 to 21 of 106
BusinessToday.In
July 6, 2020
Mylan has been licensed by Gilead for marketing the drug in 127 low- and middle-income countries, including India. The company will manufacture remdesivir at its injectables facilities in India


Reuters
July 4, 2020
A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support


BusinessToday.In
July 1, 2020
Remdesivir supply: US Department of Health and Human Services said it has secured 500,000 treatment courses of remdesivir for American hospitals through September


PTI
July 1, 2020
Fujifilm is conducting a clinical study on Avigan to treat COVID-19 patients in Japan and the United States and has been seeking to increase the drug's production by partnering with domestic and overseas companies


BusinessToday.In
June 30, 2020
In terms of subscriber market share for wireless services, Reliance Jio held 32.9 per cent, with Bharti Airtel at 28.35 per cent and Vodafone Idea at 28 per cent share as on February 29, 2020


BusinessToday.In
June 30, 2020
In the US, federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September


Associated Press
New Delhi, June 29, 2020
The 250,000 treatment courses that the company had donated to the US and other countries will run out in about a week, and the prices will apply to the drug after that


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus drug updates: The next batch of Hetero's Remdesivir will be sent to Kolkata, Lucknow, Patna, Indore, Bhopal, Bhubaneshwar, Ranchi, Kochi, Trivandrum, Vijayawada and Goa


Reuters
June 25, 2020
Cipla and Hetero are among a bevy of drugmakers which have licensing agreements with US-based Gilead Sciences Inc, the original manufacturer of remdesivir, to make and sell the drug in 127 low- and middle-income countries


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


Reuters
June 23, 2020
Cipla and privately held Indian drugmaker Hetero Labs on Sunday gained approval to sell generic versions of remdesivir in the country. Hetero expects to price a similar 100 milligram dose of the treatment at 5,000 to 6,000 rupees


BusinessToday.In
June 23, 2020
Ramdev Patanjali's corona medicine: Earlier this month, Balkrishna had claimed that ayurvedic medicine developed by Patanjali was able to cure at least 1,000 coronavirus patients within 5-14 days


Reuters
June 23, 2020
Indian drugmakers Hetero Labs and Cipla Ltd on Sunday gained approval to begin selling their generic versions of remdesivir in the country


PB Jayakumar
June 22, 2020
Pharma major is hopeful of exporting Fabiflu after the study proves efficacy of the drug in coronavirus treatment


Joe C Mathew
New Delhi, June 21, 2020
According to Sivakumar, Group Head - ITC's Agri-Business and Information Technology, while the actual investment figures will be decided after the rules and guidelines evolve, the company has already commenced work in terms of putting the plans together


Vivek Dubey
New Delhi, June 21, 2020
Gilead Sciences, in May, had extended a voluntary non-exclusive license to Cipla to manufacture and market Cipla's generic version of remedisvir called CIPREMI


E Kumar Sharma
New Delhi, June 21, 2020
Cipla plans to launch the drug in a couple of days, while Hetero's drug is expected to hit the market in a week


Reuters
June 21, 2020
China has not said anything about any losses in the hand-to-hand combat that took place in the heavily contested Galwan Valley in the western Himalayas, in which 20 Indian soldiers were killed and at least 76 injured


PTI
June 21, 2020
As per the survey conducted by the Retailers Association of India (RAI) with participation of more than 100 big and small retailers, it was found that lockdown relaxations did not benefit retailers as there was no significant surge in their business


BusinessToday.In
New Delhi, June 21, 2020
Trump added, \"We may even go very tight for a big period of time. The US has been dealing with high unemployment rates following business closures on account of the Covid19 pandemic\"


PAGES 1 OF 6  12345